Skip to content. | Skip to navigation

Personal tools

  • Le CIRI sur Linkedin
Sections

Managing bodies

logo Inserm      logo cnrslogo ENSL       logo ucb1


Secondary managing bodies

logo ENSL logo ucb1

You are here: Home
 
Publications
Urban environment and RSV: a retrospective observational study of neighbourhood factors associated with the risk of severe disease in the infant population of a metropolitan area, Lyon, France Publications of RSV Study Group Lyon
Natural killer (NK) cells have antitumor activity that is primed by IL-15 and IL-18, components of a cytokine cocktail used in NK cell–based cancer immunotherapy. Fallone et al. found that IL-15 and IL-18 synergized to activate the complex mTORC1, which resulted in increased proliferation and function of both mouse and human NK cells. IL-15 and IL-18 stimulated mTORC1 activity through distinct pathways not previously implicated in its regulation. The combination of IL-15 and IL-18 improved the survival of mice engrafted with tumor cells, suggesting a therapeutic strategy to enhance the efficacy of NK cell–based cancer immunotherapy
Lung virome convergence precedes hospital-acquired pneumonia in intubated critically ill patients Anani et al. Cell Rep Medicine - Team VirPath-CARVI
The dual-specificity kinase DYRK1A interacts with the Hepatitis B virus genome and regulates the production of viral RNA Pastor et al., Plos One, 2024 / Team HepVir
Deciphering the phospho-signature induced by hepatitis B virus in primary human hepatocytes Pastor et al., Frontiers Mircrobiology, 2024 / Team HepVir
Nicolas Kern Coquillat, Louis Picq, Ameline Hamond, Pierre Megy, Sarah Benezech, Annabelle Drouillard, Nina Lager-Lachaud, Edern Cahoreau, Marielle Moreau, Lucie Fallone, Anne-Laure Mathieu, Floriant Bellvert, Carine Nizard, Anne-Laure Bulteau, Thierry Walzer, Antoine Marçais /// Nature Metabolism, 2025 Jan 3
 
News
Two recent papers, resulting from international collaborations between Bénédicte PY, DR INSERM, NLRP3 Team, and BioAge Labs in the US, R. Coll in Ireland, M. Geyer in Germany, and R. Karki in Korea, are featured in a joint highlight in Nature Reviews Drug Discovery: www.nature.com/articles/d41
Peter Sudmant (UC Berkeley, USA), David Enard (Univ. Arizona, USA) and Lucie Etienne (CIRI, CNRS / ENS Lyon, France) are inviting you to register for the “Host adaptations to viral infections” Meeting that they are organizing from May 10th to May 13th 2026.
Le CIRI compte 12 projets qui ont été retenus pour un financement dans le cadre de l'appel à projets générique ANR 2025. Nous vous en faisons découvrir les détails ici.
Le CIRI participera à la conférence annuelle du Musée de Sciences Biologiques Docteur Mérieux à l'occasion de la Fête de la Science.
A l'occasion de reportages en immersion dans le Centre Hospitalier de Lyon, le professeur Axel Villani s'exprime sur cette pathologie méconnue dans deux vidéos destinées aux professionnels.
Le Conseil européen de la recherche (ERC) a annoncé les lauréats 2025 de la bourse "Starting Grant". François Rousset (GenoMics) a obtenu avec succès cette bourse dédiée aux jeunes chercheurs et chercheuse portant des projets d'excellence, avec son projet "Conservation of defense and anti-defense mechanisms across the tree of life" (CODA).
Job offers
The HEAL team is seeking for a PhD candidate to start a research project on the cellular and molecular aspects of “Orthonairovirus: molecular determinants of transmission”
The VIRPATH laboratory at the International Center for Research in Infectiology (CIRI) is inviting applications from motivated, independent postdoctoral researchers to lead cutting-edge projects foc (...)
L’équipe dirigée par Olivier Thaunat recrute un·e ingénieur·e en Immunologie dans le cadre d’un projet ANR portant sur les mécanismes d’allo-reconnaissance en transplantation
PERSIST Lab - Nicolas Personnic
Post-doc offer at the CERP (Center of Excellence in Respiratory Pathogens)
PERSIST Lab - Nicolas Personnic
To heighten its projects on the molecular and cellular virology of the Crimean-Congo hemorrhagic fever virus (CCHFV), HEAL, the Hepatotropic & Emerging Agents Laboratory is seeking to recruit: - A (...)
A PhD under a "CIFRE convention" is opened in EIA team. It will start in September 2024.
EVIR Team: "Genetic reprogramming of B cells to enhance their therapeutic properties before autologous transfer"
A 2-year post-doctoral position for a highly motivated and talented postdoctoral fellow is available in the team of Dr Marc Vocanson at the Centre International de Recherche en Infectiologie (CIRI), (...)
Agenda

Conferences

2025 Annual meeting of the French Dendritic Cell Society (CFCD)

Helena Paidassi will be at the Curie Institute on December 4 and 5 to present her research findings (...)

Symposium of the French Network on Monocytes-Macrophages

Le huitième Symposium du réseau francais monocytes/macrophages aura lieu à Lyon le 7 novembre (...)

SYMPOLEGIO 2024
NK/ILC symposium 2024 (16-18.10.24)

The NK/ILC symposium 2024 will take place at the amphithéatre Mérieux, Ecole Normale Supérieure, (...)

Seminars

Séminaire CIRI: Dr. Sami JANNIN (12.11.2025)

“ Vers une résonance magnétique 10000 fois plus sensible au service de la biologie ”

Séminaire CIRI: Dr. Aileen ROWAN (06.11.2025)

“ Somatic mutations HTLV-1 carriers- early predictors of malignant transformation ”

Thesis defenses

Soutenance de thèse de Chloé Teixeira, équipe StaPath (24/10/2025)

Impact des modifications post-transcriptionnelles des ARN sur la virulence de Staphylococcus aureus

Soutenance de thèse de Mathias Carriou, équipe B.Lina (17/10/2025)

Interactions interrègnes : comment la levure Candida albicans module-t-elle la virulence de la (...)